This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SLIM Obesity ETF (SLIM) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Obesity ETF (NASDAQ:SLIM) 30 days 90 days 365 days Advanced Chart Get Obesity ETF alerts:Sign Up Key Stats Today's Range$33.17▼$33.1750-Day Range$33.17▼$33.1752-Week Range$31.59▼$43.40VolumeN/AAverage Volume4,086 shsMarket Capitalization$9.95 millionAssets Under Management$13.68 millionDividend Yield0.66%Net Expense Ratio0.50%Aggregate RatingN/A ETF Overview Read More Obesity ETF ExpensesTypeSLIMHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.56%0.56%0.54%0.53%Other Expenses0.00%0.47%0.56%0.52%0.56%Total Expense0.50%0.75%0.76%0.74%0.73%Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%Net Expense0.50%0.60%0.63%0.63%0.60% Receive SLIM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Obesity ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address SLIM ETF News HeadlinesTerns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology CatalystsJuly 11 at 12:01 PM | seekingalpha.comRhythm: Oral Bivamelagon Data Signals Dominance In Hypothalamic Obesity MarketJuly 10 at 4:19 PM | seekingalpha.comYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…July 13 at 2:00 AM | Crypto 101 Media (Ad)Zealand Pharma Obesity Therapy Shows Positive Trial ResultsJune 18, 2025 | marketwatch.comBeyond Obesity: Eli Lilly's Genetic Medicine Bet On Verve TherapeuticsJune 18, 2025 | forbes.comFresenius Medical Care CEO Says Company Could Benefit From Obesity DrugsJune 17, 2025 | wsj.comSee More Headlines SLIM ETF - Frequently Asked Questions What other stocks do shareholders of Obesity ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Obesity ETF investors own include ServiceNow (NOW), SolarEdge Technologies (SEDG), Supernus Pharmaceuticals (SUPN), Teva Pharmaceutical Industries (TEVA), Galmed Pharmaceuticals (GLMD), American Noble Gas (INFY) and Nightstar Therapeutics (NITE). Fund Details IssuerJanus Henderson Fund NameThe Obesity ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:SLIM Inception Date6/8/2016 Fund ManagerBenjamin Wang, Scott M. Weiner WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkSolactive Obesity Index CategorySector FocusHealth Care Development LevelBlended Development RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$13.68 million Average Daily Volume$2.33 thousand Discount/Premium-0.38% Administrator, Advisor and Custodian AdministratorJanus Capital Management LLC AdvisorJanus Capital Management LLC CustodianState Street Bank and Trust Company DistributorALPS Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares300,000BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report SLIM Sector ExposureSLIM Industry Exposure This page (NASDAQ:SLIM) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Obesity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Obesity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
